Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition

Abstract Background Thrombotic microangiopathy (TMA) is a potentially organ and life-threatening condition affecting patients with multiple myeloma (MM). Cases of proteasome inhibitor-induced TMA and specifically carfilzomib-induced TMA have been rarely reported and standards for diagnostic workup a...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Lorenzo Catanese, Katharina Link, Harald Rupprecht
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2023-06-01
Seri Bilgileri:	BMC Nephrology
Konular:	Case report Thrombotic microangiopathy (TMA) Multiple myeloma (MM) Carfilzomib Eculizumab
Online Erişim:	https://doi.org/10.1186/s12882-023-03228-9
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!